Search Results 511-520 of 17070 for egfr

1. Phase 2 Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of DCR-PHXC Solution for Injection (subcutaneous use) in Patients with Primary Hyperoxaluria - PHYOX 2 - Mayo Clinic

   Estimated glomerular filtration rate (eGFR) at screening ≥ 30 mL/min normalized to 1.73 m2 BSA calculated using Chronic Kidney Disease Epidemiology ...

2. Dapagliflozin in Type 2 Diabetes or Pre-diabetes, and PRESERVED Ejection Fraction Heart Failure - Mayo Clinic

   Estimated glomerular filtration rate (eGFR) < 30 at the screening visit; Admission for an acute coronary syndrome (ST-elevation MI, non-ST-elevation MI, or ...

3. Transforming ECG Education Isn't All Fun and Games, Except When It Is - News Archive

   Mayo Clinic resident Anthony Kashou, M.D., has taken it upon himself to teach health care providers the fundamentals of reading ECGs, all in the name of ...

4. A Study Of The Efficacy And Safety Of Danicamtiv In Participants With Symptomatic Genetic And Familial Dilated Cardiomyopathy - Mayo Clinic

   Severe renal insufficiency (defined at the time of Screening as current estimated glomerular filtration rate \[eGFR\] \<15 mL/min/1.73m2 by simplified ...

5. A Randomized, Placebo-controlled, Double-blind, Multi-center Phase 2/3 Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot (CAM2029) in Patients with Symptomatic Polycystic Liver Disease - Mayo Clinic

   - Severe kidney disease, as defined by eGFR <30 mL/min/1.73^m2 - Severe liver disease defined as liver cirrhosis of Child-Pugh class C - Any other current ...

6. A Study of Levosimendan in Pulmonary Hypertension (PH) with Heart Failure (HF) and Preserved Left Ventricular Ejection Fraction (pEF) Patients - Mayo Clinic

   Estimated glomerular filtration rate (eGFR) < 30 mL/min/1.73m2. Liver dysfunction with Child Pugh Class B or C. Evidence of systemic bacterial, systemic ...

7. Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer - Mayo Clinic

   Participation eligibility · Any prior treatment with erlotinib or other agent whose primary mechanism of action is known to inhibit EGFR. · History of allergic ...

8. Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With Recent Embolic Stroke of Undetermined Source (ESUS) - Mayo Clinic

   Estimated glomerular filtration rate (eGFR) < 30 mL/min/1.73 m2. Participating Mayo Clinic locations. Study statuses change often. Please contact the study ...

9. A Study to Assess an Intact Parathyroid Hormone Assay Under Development by Ortho Clinical Diagnostics

   eGFR of less than 20 mL/min/1.73 m^2 (can be from Standard of Care result). Clinical diagnosis of Secondary Hyperparathyroidism. Able to provide a minimum ...

10. Study to Evaluate the Effects of Vitamin B3 Derivative on Bone, Skeletal, Muscle and Metabolic Functions in Aging - Mayo Clinic

    Estimated Glomerular Filtration Rate (eGFR) < 30 mL/min. Poorly controlled Diabetes Mellitus (HbA1c>8). Clinical History Exclusion Criteria: Confirmed ...